Recombinant RSV (Palivizumab Biosimilar) antibody

Catalog No. ABIN7487813

This Mammalian Cells Monoclonal antibody specifically detects RSV (Palivizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant RSV (Palivizumab Biosimilar) antibody (ABIN7487813)

Target: RSV (Palivizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This RSV (Palivizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-RSV (Palivizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Palivizumab Biosimilar - Anti-RSV mAb

Characteristics: Antibody Type: IgG1-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for RSV (Palivizumab Biosimilar)

Target: RSV (Palivizumab Biosimilar)

Target Type: Biosimilar

Background: MEDI-493, Synagis
Palivizumab is a humanized monoclonal antibody of isotype IgG1k produced by recombinant DNA technology. It targets the epitope in the A antigenic site of the respiratory syncytial virus (RSV) F protein.

CAS-No: 188039-54-5